scholarly journals Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort

2021 ◽  
Author(s):  
Lorenz M. Pammer ◽  
Claudia Lamina ◽  
Ulla T. Schultheiss ◽  
Fruzsina Kotsis ◽  
Barbara Kollerits ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Major Adverse Cardiac Events ◽  
Cardiac Events ◽  
The Metabolic Syndrome ◽  
Adverse Cardiac Events

Abstract 1691: Stages of Chronic Kidney Disease Correlate with Major Adverse Cardiac Events as well as Late Lumen Loss Following the Sirolimus Eluting Coronary Stent

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Yota Kawamura ◽  
Yoshihiro Morino ◽  
Masakazu Nagaoka ◽  
Takashi Matsukage ◽  
Naoki Masuda ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Stent Implantation ◽  
Major Adverse Cardiac Events ◽  
Drug Eluting Stent ◽  
Maximum Pressure ◽  
Cardiac Events ◽  
Late Lumen Loss ◽  
Adverse Cardiac Events

Background: Chronic Kidney Disease (CKD) is considered as a risk factor for development of cardiovascular disease. However, it is unclear whether CKD has association with prognosis following the drug eluting stent implantation. Methods and Results : The Cypher coronary stents were implanted to 302 lesions in 249 patients who underwent elective PCI between January 2005 and April 2006. Average age was 66.3 ± 9.7 and male gender was 80.3%. Diabetes was found in 47% of the patients including 16% of insulin treatment. Stages of CKD are shown in the table 1 and 2 . AHA/ACC lesion type B2/C was 62%. Cypher stents were implanted at maximum pressure at 17.3 ± 3.0 atm. Intravascular ultrasound was used in 92% of the procedure. Clinical follow-up data were available in 89.9 % at 1 year although angiographic follow-up was performed in 73.1% at 8 months. Major adverse cardiac events were frequently observed in association with stages of CKD as shown in the table 1 . Stages of CKD have correlation with late lumen loss at 8 months (Table 2 ). Furthermore, in-stent late lumen loss inversely correlated with glomerular filtration rate (GFR) (R = −0.18, p = 0.0097). Conclusion : Stages of CKD have correlation with major adverse cardiac events as well as late lumen loss following the sirolimus eluting stent implantation. Clinical follow-up at 1 year of study stratified by stages of CKD Angiographic data of study stratified by stages of CKD

Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events

2012 ◽  
Vol 26 (1) ◽  
pp. 111-118 ◽  
Author(s):  
Chao-Ping Wang ◽  
Li-Fen Lu ◽  
Teng-Hung Yu ◽  
Wei-Chin Hung ◽  
Cheng-An Chiu ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Major Adverse Cardiac Events ◽  
Cardiac Events ◽  
Adverse Cardiac Events ◽  
Total P

The metabolic syndrome and chronic kidney disease

2006 ◽  
Vol 15 (4) ◽  
pp. 361-365 ◽  
Author(s):  
Carmen A Peralta ◽  
Manjula Kurella ◽  
Joan C Lo ◽  
Glenn M Chertow
Keyword(s):  
Metabolic Syndrome ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
The Metabolic Syndrome

scholarly journals The Metabolic Syndrome and Risk of Chronic Kidney Disease: Pathophysiology and Intervention Strategies

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Heather A. LaGuardia ◽  
L. Lee Hamm ◽  
Jing Chen
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Intervention Strategies ◽  
Elevated Blood ◽  
The Metabolic Syndrome ◽  
Prevalence Of Obesity ◽  
Complications And Mortality

Metabolic syndrome is characterized by a clustering of cardiovascular risk factors, including abdominal obesity, elevated blood pressure and glucose concentrations, and dyslipidemia. The presence of this clinical entity is becoming more pervasive throughout the globe as the prevalence of obesity increases worldwide. Moreover, there is increased recognition of the complications and mortality related to this syndrome. This paper looks to examine the link between metabolic syndrome and the development of chronic kidney disease.

Sign in / Sign up

Export Citation Format

Share Document